BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

T2 Biosystems 

101 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-457-1200 Fax: 781-357-3080


SEARCH JOBS




Industry
Diagnostics






 Company News
T2 Biosystems (TTOO) Receives FDA Authorization To Market T2Candida And T2Dx For The Detection Of Sepsis-Causing Pathogens 9/23/2014 7:43:19 AM
T2 Biosystems (TTOO) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/2/2014 8:02:37 AM
T2 Biosystems (TTOO) Announces Closing Of Initial Public Offering 8/12/2014 3:07:06 PM
Massachusett's T2 Biosystems (TTOO) Goes Public, Raises $57 Million 8/7/2014 7:39:22 AM
MRI Diagnostics Maker T2 Biosystems Boosts IPO Cap To $78.2 Million 7/31/2014 7:25:26 AM
Diagnostics Developer T2 Biosystems Files For A $69 Million IPO 7/3/2014 7:39:07 AM
T2 Biosystems Release: Clinical Chemistry Study Reports On Use Of T2MR To Evaluate Hemostasis In Whole Blood 6/23/2014 11:08:27 AM
T2 Biosystems Submits 510(K) Application To The FDA For Review Of T2Dx And T2Candida 6/3/2014 9:52:28 AM
T2 Biosystems Presents New Data At The Thrombosis And Hemostasis Summit Of North America Demonstrating Ability Of T2MR Platform Technology To Measure Platelet Activity And Additional Hemostasis Parameters 4/10/2014 7:31:28 AM
T2 Biosystems Appoints Michael Pfaller, MD, Chief Medical Officer 4/3/2014 2:27:15 PM
123456